Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy
Clinical trial NCT04281485 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04281485
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-05
- Primary completion
- 2024-05-15
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.